
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
The feud between Novo Nordisk (NYSE:NVO) and Hims & Hers (NYSE:HIMS) has been one of the most dramatic storylines in biotech investing — and it just took a major new turn. Simon Erickson breaks down the four-year saga: f...
Mar 13, 2026: Novo Nordisk vs. Hims & Hers: The GLP-1 Feud That Could Define a $200 Billion Market is an episode from The 7investing Podcast by 7investing. The feud between Novo Nordisk (NYSE:NVO) and Hims & Hers (NYSE:HIMS) has been one of...
This episode belongs to The 7investing Podcast.
Use the player on this page to stream the episode online.
Published Apr 3, 2026, 00:32:51 long, audio available.